Human and murine cytomegalovirus evasion of cytotoxic T lymphocyte and natural killer cell-mediated immune responses

Seminars in Virology

Volumn 8, Issue 5, 1998, Pages 369-376

  Davis Poynter, Nicholas J ^a   Farrell, Helen E ^a  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CD8 ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; VIRUS PROTEIN;

ANTIGEN PRESENTATION; CELLULAR IMMUNITY; CYTOMEGALOVIRUS; CYTOTOXIC T LYMPHOCYTE; HUMAN; IMMUNE RESPONSE; NATURAL KILLER CELL; NONHUMAN; PROTEIN ASSEMBLY; REVIEW; VIRUS GENE;

CYTOMEGALOVIRUS; MOUSE CYTOMEGALOVIRUS 1; MURINAE;

EID: 0031803980     PISSN: 10445773     EISSN: None     Source Type: Journal    
DOI: 10.1006/smvy.1997.0142     Document Type: Article

References (51)

1. McGeoch D. J., Cook S., Dolan A., Jamieson F. E., Telford E. A. Molecular phylogeny and evolutionary timescale for the family of mammalian herpesviruses. J. Mol. Biol. 247:1996;443-458.
2. Spriggs M. K. One step ahead of the game: Viral immunomodulatory molecules. Annu. Rev. Immunol. 14:1996;101-130.
3. Davis-Poynter N. J., Farrell H. E. Masters of deception: a review of herpesvirus immune evasion strategies. Immunol. Cell Biol. 74:1996;512-522.
4. Del Val M., Münch K., Reddehase M. J., Koszinowski U. H. Presentation of cytomegalovirus immediate-early antigen to cytolytic T lymphocytes is selectively prevented by viral genes expressed in the early phase. Cell. 58:1989;305-315.
5. Del Val M., Hengel H., Häcker H., Hartlaub U., Ruppert T., Lucin P., Koszinowski U. H. Cytomegalovirus prevents antigen presentation by blocking the transport of peptide loaded major histocompatibility complex class I molecules into the medial-golgi compartment. J. Exp. Med. 176:1992;729-738.
6. Beersma M. F. C., Bijlmakers M. J. E., Ploegh H. L. Human cytomegalovirus down-regulates HLA class I expression by reducing the stability of class I H chains. J. Immunol. 151:1993;4455-4464.
7. Warren A. P., Ducroq D. H., Lehner P. J., Borysiewicz L. K. Human cytomegalovirus-infected cells have unstable assembly of major histocompatibility complex class I complexes and are resistant to lysis by cytotoxic T lymphocytes. J. Virol. 68:1994;2822-2829.
8. Michaelek M. T., Grant E. P., Gramm C., Goldberg A. L., Rock K. L. A role for the ubiquitin dependent proteolytic pathway in MHC class-I restricted antigen presentation. Nature. 363:1993;552-554.
9. Monaco J. J., Nandi D. The genetics of proteasomes and antigen processing. Annu. Rev. Genet. 29:1995;729-754.
10. Lehner P. J., Cresswell P. Processing and delivery of peptides presented by MHC class I molecules. Curr. Opin. Immunol. 8:1996;59-67.
11. Townsend A., Trowsdale J. The transporters associated with antigen presentation. Semin. Cell. Biol. 4:1993;53-61.
12. Neefjes J. J., Momburg F., Hämmerling G. J. Selective and ATP-dependent translocation of peptides by the MHC-encoded transporter. Science. 261:1993;769-771.
13. Shepherd J. C., Schumacher T. N. M., Ashton-Rickardt P. G., Imeda S., Ploegh H., Janeway C. A., Tonegawa S. TAP1-dependent peptide translocation in vitro is ATP-dependent and selective. Cell. 74:1993;577-584.
14. Androlewicz M. J., Anderson K. S., Cresswell P. Evidence that transporters associated with antigen processing translocate a major histocompatibility complex class I-binding peptide into the endoplasmic reticulum in an ATP-dependent manner. Proc. Natl. Acad. Sci. USA. 90:1993;9130-9134.
15. Gilbert M. J., Riddell S. R., Plachter B., Greenberg P. D. Cytomegalovirus selectively blocks antigen processing and presentation of its immediate-early gene product. Nature. 383:1996;720-722.
16. Hengel H., Flohr T., Hämmerling G. J., Koszinowski U. H., Momburg F. Human cytomegalovirus inhibits peptide translocation into the endoplasmic reticulum for MHC class I assembly. J. Gen. Virol. 77:1996;2987-2296.
17. Hengel H., Koopmann J.-O., Flohr T., Muranyi W., Goulmy E., Hämmerling G. J., Koszinowski U., Momburg F. A viral ER-resident glycoprotein inactivates the MHC-encoded peptide transporter. Immunity. 6:1997;623-632.
18. Ahn K., Gruhler A., Galocha B., Jones T. R., Wiertz E. J. H. J., Ploegh H. L., Peterson P. A., Yang Y., Fruh K. The ER-lumenal domain of the HCMV glycoprotein US6 inhibits peptide translocation by TAP. Immunity. 6:1997;613-621.
19. Sadasivan B., Lehner P. J., Ortmann B., Spies T., Cresswell P. Roles for calreticulin and a novel glycoprotein, tapasin, in the interaction of MHC class I molecules with TAP. Immunity. 5:1996;103-114.
20. Hill A., Massuchi M. Avoiding immunity and apoptosis: manipulation of the host environment by herpes simplex virus and Epstein-Barr virus. Semin. Virol. 1997.
21. Browne H., Smith G., Beck S., Minson T. A complex between the MHC class I homologue encoded by human cytomegalovirus and β2-microglobulin. Nature. 347:1990;770-771.
22. Jones T. R., Hanson L. K., Sun L., Slater J. S., Stenberg R. M., Campbell A. E. Multiple independent loci within the human cytomegalovirus unique short region down-regulate expression of major histocompatibility complex class I heavy chains. J. Virol. 69:1995;4830-4841.
23. Wiertz E. J. H. J., Tortorella D., Bogyo M., Yu J., Mothes W., Jones T. R., Rapaport T. A., Ploegh H. L. Sec61-mediated transfer of a membrane protein from the endoplasmic reticulum to the proteasome for destruction. Nature. 384:1996;432-438.
24. Wiertz E. J. H. J., Jones T. R., Sun L., Bogyo M., Geuze H. J., Ploegh H. L. The human cytomegalovirus US11 gene product dislocates MHC class I heavy chains from the endoplasmic reticulum to the cytosol. Cell. 84:1996;769-779.
25. Rapoport T. A., Jungnickel B., Kutay U. Protein transport across the eukaryotic endoplasmic reticulum and bacterial inner membranes. Annu. Rev. Biochem. 65:1996;271-303.
26. Thäle R., Szepan U., Hengel H., Geginat G., Lucin P., Koszinowski U. H. Identification of the mouse cytomegalovirus genomic region affecting major histocompatibility complex class I molecule transport. J. Virol. 69:1995;6098-6105.
27. Ziegler H., Thäle R., Lucin P., Muranyi W., Flohr T., Hengel H., Farrell H., Rawlinson W., Koszinowski U. H. A mouse cytomegalovirus glycoprotein retains MHC class I complexes in the ERGIC/cis-Golgi compartments. Immunity. 6:1997;57-66.
28. Ahn K., Angulo A., Ghazal P., Peterson P., Yang Y., Früh K. Human cytomegalovirus inhibits anigen presentation by a sequential multistep process. Proc. Natl. Acad. Sci. USA. 93:1996;10990-10995.
29. Jones T. R., Wiertz E. J. H. J., Sun L., Fish K. N., Nelson J. A., Ploegh H. L. Human cytomegalovirus US3 impairs transport and maturation of major histocompatibility complex class I heavy chains. Proc. Natl. Acad. Sci. USA. 93:1996;11327-11333.
30. Kleijnen M. F., Huppa J. B., Lucin P., Mukherjee S., Farrell H., Campbell A. E., Koszinowski U. H., Hill A. B., Ploegh H. L. A mouse cytomegalovirus glycoprotein, gp34, forms a complex with folded class I MHC molecules in the ER which is not retained but is transported to the cell surface. EMBO J. 16:1997;685-694.
31. Machold R. P., Wiertz E. J. H. J., Jones T. R., Ploegh H. L. The HCMV gene products US11 and US2 differ in their ability to attack allelic forms of murine major histocompatibility complex (MHC) class I heavy chains. J. Exp. Med. 185:1997;363-366.
32. Jones T. R., Sun L. Human cytomegalovirus US2 destabilizes major histocompatibility complex class I heavy chains. J. Virol. 71:1997;2970-2979.
33. Beck S., Barrell B. G. Human cytomegalovirus encodes a glycoprotein homologous to MHC class I antigens. Nature. 331:1988;269-272.
34. Wiley D. Molecular immunology: MHC gene in cytomegalovirus. Nature. 331:1988;209-210.
35. Browne H., Churcher M., Minson T. Construction and characterization of a human cytomegalovirus mutant with the UL18 (class I homolog) gene deleted. J. Virol. 66:1992;6784-6787.
36. Fahnestock M. L., Johnson J. L., Feldman R. M. R., Neveu J. M., Lane W. S., Bjorkman P. J. The MHC class I homolog encoded by human cytomegalovirus binds endogenous peptides. Immunity. 3:1995;583-590.
37. Raulet D. H. Recognition events that inhibit and activate natural killer cells. Curr. Opin. Immunol. 8:1996;372-377.
38. Kärre K. Express yourself or die: peptides, MHC molecules and NK cells. Science. 267:1995;978-979.
39. Reyburn H. T., Mandelboim O., Valés-Gómez M., Davis D. M., Pazmany L., Strominger J. L. The class I MHC homologue of human cytomegalovirus inhibits attack by natural killer cells. Nature. 386:1997;514-517.
40. Phillips J. H., Chang C. W., Mattson J., Gumperz J. E., Parham P., Lanier L. L. CD94 and a novel associated protein (94AP) form a NK cell receptor involved in the recognition of HLA-A, HLA-B and HLA-C allotypes. Immunity. 5:1996;163-172.
41. Sivori S., Vitale M., Bottino C., Marcenaro E., Sanseverino L., Parolini S., Moretta L., Moretta A. CD94 functions as a natural killer cell inhibitory receptor for different HLA class I alleles: Identification of the inhibitory form of CD94 by the use of novel monoclonal antibodies. Eur. J. Immunol. 26:1996;2487-2492.
42. Cosman D., Fanger N., Borges L., Kubin M., Chin W., Peterson L., Hsu M.-L. A novel immunoglobulin superfamily receptor for cellular and viral MHC class I molecules. Immunity. 8. 1997;273-282.
43. Farrell H. E., Vally H., Lynch D. M., Fleming P., Shellam G. R., Scalzo A. A., Davis-Poynter N. J. Inhibition of natural killer cells by a cytomegalovirus MHC class I homologuein vivo. Nature. 386:1997;510-514.
44. Bancroft G. J., Shellam G. R., Chalmers J. E. Genetic influences on the augmentation of natural killer (NK) cells during murine cytomegalovirus infection: Correlation with patterns of resistance. J. Immunol. 126:1981;988-994.
45. Bukowski J. F., Woda B. A., Welsh R. M. Pathogenesis of murine cytomegalovirus infection in natural killer cell-depleted mice. J. Virol. 52:1984;119-128.
46. Shellam G. R., Flexman J. P., Farrell H. E., Papadimitriou J. M. The genetic background modulates the effect of the beige gene on susceptibility to cytomegalovirus infection in mice. Scand. J. Immunol. 22:1985;147-155.
47. Chee M. S., Bankier A. T., Beck S., Bohni R., Brown C. M., Cerny R., Horsnell T., Hutchison C. A., Kouzarides T., Martignetti J. A., Satchwell S. C., Tomlinson P., Weston K. M., Barrell B. G. Analysis of the protein coding content of the sequence of human cytomegalovirus strain AD169. Curr. Top. Microbiol. Immunol. 154:1990;125-169.
48. Rawlinson W. D., Farrell H. E., Barrell B. G. Analysis of the complete DNA sequence of murine cytomegalovirus. J. Virol. 70:1996;8833-8849.
49. Früh K., Ahn K., Peterson P. A. Inhibition of MHC class I antigen presentation by viral proteins. J. Mol. Med. 75:1997;18-27.
50. Ploegh H. L. Destruction of proteins as a creative force. Immunol. Today. 18:1997;269-271.
51. Bonifacino J. S. Reversal of fortune for nascent proteins. Nature. 384:1996;405-406.